Does LOMUSTINE Cause Product use in unapproved indication? 58 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Product use in unapproved indication have been filed in association with LOMUSTINE (LOMUSTINE). This represents 3.6% of all adverse event reports for LOMUSTINE.
58
Reports of Product use in unapproved indication with LOMUSTINE
3.6%
of all LOMUSTINE reports
11
Deaths
13
Hospitalizations
How Dangerous Is Product use in unapproved indication From LOMUSTINE?
Of the 58 reports, 11 (19.0%) resulted in death, 13 (22.4%) required hospitalization, and 8 (13.8%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMUSTINE. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does LOMUSTINE Cause?
Death (169)
Off label use (135)
Thrombocytopenia (127)
Disease progression (106)
Neutropenia (92)
Drug ineffective (88)
Fatigue (71)
Nausea (68)
Platelet count decreased (63)
Malignant neoplasm progression (62)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which LOMUSTINE Alternatives Have Lower Product use in unapproved indication Risk?
LOMUSTINE vs LONAPEGSOMATROPIN-TCGD
LOMUSTINE vs LONCASTUXIMAB TESIRINE-LPYL
LOMUSTINE vs LOPERAMIDE
LOMUSTINE vs LOPINAVIR
LOMUSTINE vs LOPINAVIR\RITONAVIR